| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CHEM.201704167 |
| P8608 | Fatcat ID | release_7prboqmhvbed5iowo3p2dtjj4y |
| P698 | PubMed publication ID | 28991382 |
| P50 | author | Qi Zhang | Q57045815 |
| P2093 | author name string | Jiangtao Gao | |
| Dhanaraju Mandalapu | |||
| Xinjian Ji | |||
| Chuchu Guo | |||
| P2860 | cites work | A new antibiotic kills pathogens without detectable resistance | Q24091299 |
| Use of ichip for high-throughput in situ cultivation of "uncultivable" microbial species | Q24605448 | ||
| Structural and Functional Characterization of MppR, an Enduracididine Biosynthetic Enzyme from Streptomyces hygroscopicus : Functional Diversity in the Acetoacetate Decarboxylase-like Superfamily | Q27678584 | ||
| Streptomyces wadayamensis MppP Is a Pyridoxal 5'-Phosphate-Dependent L-Arginine α-Deaminase, γ-Hydroxylase in the Enduracididine Biosynthetic Pathway | Q27702595 | ||
| The sypA, sypB, and sypC Synthetase Genes Encode Twenty-Two Modules Involved in the Nonribosomal Peptide Synthesis of Syringopeptin by Pseudomonas syringae pv. syringae B301D | Q28203866 | ||
| Antibacterial natural products in medicinal chemistry--exodus or revival? | Q28255204 | ||
| The Activation of Free Dipeptides Promoted by Strong Activating Agents in Water Does not Yield Diketopiperazines. | Q47392948 | ||
| Converting Teixobactin into a Cationic Antimicrobial Peptide (AMP). | Q47969690 | ||
| Identification and characterization of the lysobactin biosynthetic gene cluster reveals mechanistic insights into an unusual termination module architecture | Q48058009 | ||
| Defining the molecular structure of teixobactin analogues and understanding their role in antibacterial activities | Q48310474 | ||
| Antibiotics: Recover the lost art of drug discovery | Q48438044 | ||
| Efficient total syntheses and biological activities of two teixobactin analogues | Q49064838 | ||
| Syntheses of potent teixobactin analogues against methicillin-resistant Staphylococcus aureus (MRSA) through the replacement of l-allo-enduracididine with its isosteres. | Q50560970 | ||
| Multiple attack on bacteria by the new antibiotic teixobactin. | Q52866776 | ||
| Synthesis and Biological Evaluation of a Teixobactin Analogue. | Q53181587 | ||
| In vivo characterization of tandem C-terminal thioesterase domains in arthrofactin synthetase. | Q53568562 | ||
| Total Synthesis of Teixobactin. | Q53785473 | ||
| Antibakterielle Naturstoffe in der medizinischen Chemie – Exodus oder Renaissance? | Q56625626 | ||
| Re-evaluation of the N-terminal substitution and the D-residues of teixobactin | Q57179926 | ||
| Lysine Scanning of Arg-Teixobactin: Deciphering the Role of Hydrophobic and Hydrophilic Residues | Q58034891 | ||
| Synthesis and structure-activity relationship of teixobactin analogues via convergent Ser ligation | Q61779084 | ||
| The role of natural products in a modern drug discovery program | Q73396825 | ||
| Highly efficient chiral-pool synthesis of (2S,4R)-4-hydroxyornithine | Q74561107 | ||
| Where will new antibiotics come from? | Q79817299 | ||
| A Highly Stereoselective and Scalable Synthesis of L-allo-Enduracididine | Q86104359 | ||
| New antibiotic discovered for Gram-positive bacteria | Q86557856 | ||
| New twist on antibiotic hunt hits pay dirt | Q86717812 | ||
| Biosynthesis of enduracidin: Origin of enduracididine and other amino acids. | Q105240831 | ||
| Natural products as sources of new drugs over the 30 years from 1981 to 2010 | Q29616640 | ||
| Origins and evolution of antibiotic resistance | Q29617791 | ||
| ChemMatrix, a poly(ethylene glycol)-based support for the solid-phase synthesis of complex peptides | Q33236076 | ||
| The chemical arsenal of Burkholderia pseudomallei is essential for pathogenicity. | Q33879176 | ||
| Counting the uncountable: statistical approaches to estimating microbial diversity | Q33990368 | ||
| Prokaryotic diversity--magnitude, dynamics, and controlling factors | Q34127920 | ||
| Vicinal diamination of alkenes under Rh-catalysis | Q34282676 | ||
| Tackling antibiotic resistance | Q34390844 | ||
| Antibiotics: An irresistible newcomer. | Q34456690 | ||
| A new antibiotic and the evolution of resistance | Q34467725 | ||
| Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance | Q34547868 | ||
| The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics | Q34550741 | ||
| The mechanism of action of ramoplanin and enduracidin | Q34553065 | ||
| Assembly-line enzymology for polyketide and nonribosomal Peptide antibiotics: logic, machinery, and mechanisms. | Q34555236 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Antibiotic discovery goes underground: The discovery of teixobactin could revitalise the search for new antibiotics based on the novel method the researchers used to identify the compound | Q35595463 | ||
| Nonribosomal Peptide Synthesis-Principles and Prospects | Q36316177 | ||
| Protein chemical synthesis by serine and threonine ligation | Q36799143 | ||
| Limitations of vancomycin in the management of resistant staphylococcal infections | Q36916076 | ||
| Wall teichoic acids of gram-positive bacteria | Q37442758 | ||
| Elucidation of the Teixobactin Pharmacophore | Q37616543 | ||
| Wall teichoic acid function, biosynthesis, and inhibition | Q37629742 | ||
| Teichoic acid biosynthesis as an antibiotic target | Q38126648 | ||
| Molecular mechanisms of antibiotic resistance. | Q38272908 | ||
| Teixobactin, the first of a new class of antibiotics discovered by iChip technology? | Q38531889 | ||
| Teixobactin and Its Analogues: A New Hope in Antibiotic Discovery. | Q38647719 | ||
| Enduracididine, a rare amino acid component of peptide antibiotics: Natural products and synthesis | Q39112679 | ||
| Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis. | Q40566928 | ||
| Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria | Q40622160 | ||
| Massetolide A biosynthesis in Pseudomonas fluorescens. | Q42227441 | ||
| Total synthesis of teixobactin. | Q42375863 | ||
| Biosynthetic pathway for mannopeptimycins, lipoglycopeptide antibiotics active against drug-resistant gram-positive pathogens | Q42408769 | ||
| The enduracidin biosynthetic gene cluster from Streptomyces fungicidicus | Q42599363 | ||
| NRPSpredictor2--a web server for predicting NRPS adenylation domain specificity | Q42713872 | ||
| Antibiotic discovery heralds new world of drugs | Q43172591 | ||
| X-ray crystallographic structure of a teixobactin analogue reveals key interactions of the teixobactin pharmacophore. | Q46386811 | ||
| Alanine scan reveals modifiable residues in teixobactin | Q46549407 | ||
| Investigation of the N-Terminus Amino Function of Arg10-Teixobactin | Q46690045 | ||
| In silico methods for linking genes and secondary metabolites: The way forward. | Q47138590 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | teixobactin | Q18720369 |
| P577 | publication date | 2017-10-09 | |
| P1433 | published in | Chemistry—A European Journal | Q898737 |
| P1476 | title | Chemistry and Biology of Teixobactin |
| Q90320467 | Addressing Antimicrobial Resistance through New Medicinal and Synthetic Chemistry Strategies |
| Q100730666 | Biosynthesis of Depsipeptides; or Depsi: The peptides with varied generations |
| Q91744291 | Crossroads of Antibiotic Resistance and Biosynthesis |
| Q113959317 | Cyclofaulknamycin with the Rare Amino Acid D-capreomycidine Isolated from a Well-Characterized Streptomyces albus Strain |
| Q92092107 | Gram-scale total synthesis of teixobactin promoting binding mode study and discovery of more potent antibiotics |
| Q87891234 | Lipopeptidomimetics derived from teixobactin have potent antibacterial activity against Staphylococcus aureus |
| Q97686488 | Mimicry of a Non-ribosomally Produced Antimicrobial, Brevicidine, by Ribosomal Synthesis and Post-translational Modification |
| Q90415948 | New perspectives on the treatment of mycobacterial infections using antibiotics |
| Q54217425 | Rational design and synthesis of modified teixobactin analogues: in vitro antibacterial activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa. |
| Q91025129 | Solution-phase total synthesis of teixobactin |
| Q92407556 | Strategies for discovery of new molecular targets for anti-infective drugs |
| Q91625649 | Synthesis and structure-activity relationships of teixobactin |
| Q99708838 | Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model |
| Q96291752 | Teixobactin: A Paving Stone towards A New Class of Antibiotics? |
| Q95839089 | The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study |
| Q92467090 | The impact of backbone N-methylation on the structure-activity relationship of Leu10 -teixobactin |
| Q48192881 | Thioesterase-Mediated Synthesis of Teixobactin Analogues: Mechanism and Substrate Specificity. |
| Q90331505 | Total Solid-Phase Synthesis of Dehydroxy Fengycin Derivatives |
Search more.